Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
Open in App
IND
USA
IND
IND
×
Close
IND
USA
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Pfizer Ltd.
NSE: PFIZER
|
BSE: 500680
|
ISIN: INE182A01018
|
Industry: Pharmaceuticals
|
Mid-range Performer
3847.4000
-17.00
(
-0.44
%)
NSE
Nov 13, 2026
15:31 PM
26.81% Fall from 52W High
Volume:
12,669
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Pfizer Ltd.
edited
02 Dec 2020
3847.40
-0.44%
Pfizer-BioNTech's Covid-19 vaccine gets EUA for use in UK
Business Line
Still a long shot for India, given its distribution challenges
ICICI Securities Limited decreased Buy price target of Pfizer Ltd. to 4800.0 on 04 Nov, 2026.
UK approves Pfizer's COVID-19 vaccine: When will it come to India and all other questions answered
Moneycontrol |
02 Dec 2020
9 more
Pfizer share climbs 5% after UK approves COVID-19 vaccine
Business Today |
02 Dec 2020
UK OKs Pfizer-BioNTech Vaccine For Use In Global First
NDTV Profit |
02 Dec 2020
Pfizer shares jump over 5% on reports of UK authorising its COVID-19 vaccine
Moneycontrol |
02 Dec 2020
UK approves Pfizer-BioNTech Covid vaccine; to be available from next week
Business Standard |
02 Dec 2020
UK approves Pfizer-BioNTech vaccine for use
Business Line |
02 Dec 2020
UK approves Pfizer-BioNTech COVID-19 vaccine; rollout to begin next week
Moneycontrol |
02 Dec 2020
Breaking: UK becomes first country to approve Pfizer & BioNTech vaccine for mass use
Business Today |
02 Dec 2020
Mexico set to sign deal with Pfizer for delivery of Covid-19 vaccine
Business Standard |
02 Dec 2020
Letters to the editor dated December 2, 2020
Business Line |
02 Dec 2020
More from Pfizer Ltd.
Recommended
Pre Monday: New opportunities as markets rise, and some tears
The Baseline |
14 Nov 2026, 12:00PM
Not all revenue beats are equal: inside Q2’s biggest surprises
The Baseline |
13 Nov 2026, 06:04PM
Earnings Call Transcript - Pfizer
|
04 Feb 2020